Zhuang W, Xiao G, Zhang M, Wang J, et al. GPC3 chimeric antigen receptor (CAR)-NK cells combined with Enoblituzumab enhance the anti-tumor efficacy against hepatocellular carcinoma. Biochem Biophys Res Commun 2026;829:154190.
PMID: 42378857